Takip et
Professor Usha Menon
Professor Usha Menon
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College
ucl.ac.uk üzerinde doğrulanmış e-posta adresine sahip - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
14822011
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92-94, 2017
12902017
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
11402016
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
11182015
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
Collaborative Group on Hormonal Factors in Breast Cancer
The lancet oncology 13 (11), 1141-1151, 2012
10832012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ...
The lancet oncology 13 (4), 385-394, 2012
10692012
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK …
U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...
The lancet oncology 10 (4), 327-340, 2009
10232009
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ...
Genome research 20 (4), 440-446, 2010
9182010
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ...
The American Journal of Human Genetics 104 (1), 21-34, 2019
8862019
Management of women who test positive for high-risk types of human papillomavirus: the HART study
J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ...
The Lancet 362 (9399), 1871-1876, 2003
7672003
Screening for ovarian cancer: a pilot randomised controlled trial
IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ...
The Lancet 353 (9160), 1207-1210, 1999
7271999
Progress and challenges in screening for early detection of ovarian cancer
IJ Jacobs, U Menon
Molecular & Cellular Proteomics 3 (4), 355-366, 2004
6762004
New tumor markers: CA125 and beyond
RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ...
International Journal of Gynecologic Cancer 15 (Suppl 3), 2005
6742005
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6422013
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ...
Journal of the National Cancer Institute 107 (11), djv214, 2015
4842015
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ...
The lancet oncology 14 (9), 853-862, 2013
4522013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
4132013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
3992021
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ...
Nature genetics 42 (10), 874-879, 2010
3892010
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
3862017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20